CoLucid Pharmaceuticals
CoLucid Pharmaceuticals, Inc., a biotechnology company, focuses on therapies for central nervous system disorders. The company develops COL-144, a neurally acting anti-migraine agent, which is designed to treat migraine; and COL-204, a conjugated...Homepage: http://www.colucid.com/
Total money raised: $7.5M
Phone: 919-806-4304
Updated on Aug 30, 2011
CoLucid Pharmaceuticals at CrunchBase
Artthur M. Pappas CEO and ChairmanCoLucid Pharmaceuticals at CrunchBase
Jesse I. Treu Board of Director
Past
August, 2011
CoLucid Pharmaceuticals raised $7.5M in unattributed round from Pappas Ventures, Domain Associates, Care Capital, Pearl Street Venture Funds, and Triathlon Medical Venture Partners
CoLucid Pharmaceuticals Raises $7.5 Million of Planned $9.5 Million 
prnewswire.com